These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 21558138)
1. Elevated circulating CD4+ ICOS+ Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus. Liu Y; Zhu T; Cai G; Qin Y; Wang W; Tang G; Zhao D; Shen Q Lupus; 2011 May; 20(6):620-7. PubMed ID: 21558138 [TBL] [Abstract][Full Text] [Related]
2. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033 [TBL] [Abstract][Full Text] [Related]
3. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus. Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus. Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598 [TBL] [Abstract][Full Text] [Related]
5. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis. Bonelli M; von Dalwigk K; Savitskaya A; Smolen JS; Scheinecker C Ann Rheum Dis; 2008 May; 67(5):664-71. PubMed ID: 17728327 [TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus]. Yang JH; Shen Q; Zhao DB; Cai Q; Han XH Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508 [TBL] [Abstract][Full Text] [Related]
7. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064 [TBL] [Abstract][Full Text] [Related]
8. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986 [TBL] [Abstract][Full Text] [Related]
9. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients. Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042 [TBL] [Abstract][Full Text] [Related]
10. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis. Xing Q; Su H; Cui J; Wang B Immunol Invest; 2012; 41(1):15-27. PubMed ID: 21563925 [TBL] [Abstract][Full Text] [Related]
11. Role of interleukin-10 and transforming growth factor beta 1 in otitis media with effusion. Zhao SQ; Li J; Liu H; Zhang QG; Wang Y; Han DM Chin Med J (Engl); 2009 Sep; 122(18):2149-54. PubMed ID: 19781301 [TBL] [Abstract][Full Text] [Related]
12. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus. Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242 [TBL] [Abstract][Full Text] [Related]
13. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis. Enghard P; Langnickel D; Riemekasten G Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368 [TBL] [Abstract][Full Text] [Related]
14. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820 [TBL] [Abstract][Full Text] [Related]
15. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production. Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187 [TBL] [Abstract][Full Text] [Related]
16. Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus. Mellor-Pita S; Citores MJ; Castejon R; Yebra-Bango M; Tutor-Ureta P; Rosado S; Andreu JL; Vargas JA Cytometry B Clin Cytom; 2009 Jul; 76(4):261-70. PubMed ID: 19199277 [TBL] [Abstract][Full Text] [Related]
17. Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus. Barath S; Aleksza M; Tarr T; Sipka S; Szegedi G; Kiss E Lupus; 2007; 16(7):489-96. PubMed ID: 17670847 [TBL] [Abstract][Full Text] [Related]
18. Increased CCR4 expression on circulating CD4(+) T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus. Yang PT; Kasai H; Zhao LJ; Xiao WG; Tanabe F; Ito M Clin Exp Immunol; 2004 Nov; 138(2):342-7. PubMed ID: 15498047 [TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity. Slobodin G; Ahmad MS; Rosner I; Peri R; Rozenbaum M; Kessel A; Toubi E; Odeh M Cell Immunol; 2010; 261(2):77-80. PubMed ID: 20096404 [TBL] [Abstract][Full Text] [Related]
20. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Yudoh K; Matsuno H; Nakazawa F; Yonezawa T; Kimura T Arthritis Rheum; 2000 Mar; 43(3):617-27. PubMed ID: 10728756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]